Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, announced that it is scheduled to speak at the UBS 2010 Global Healthcare Services Conference in New York City. The presentation is scheduled for Wednesday, February 10, 2010 at 9:00 a.m. Eastern Time.
During the conference, the company will reaffirm its 2010 guidance for revenue growth of 3% to 4%, operating income to approach 19% of revenues, and diluted earnings per share of between $4.10 and $4.30.
SOURCE Quest Diagnostics
RELATED LINKS
http://www.QuestDiagnostics.com